T helper 17 cells play a critical pathogenic role in lung cancer
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Lung cancer development is associated with extensive pulmonary inflammation. In addition, the linkage between chronic obstructive pulmonary disease (COPD) and lung cancer has been demonstrated in population-based studies. IL-17-producing CD4 helper T cells (Th17 cells) play a critical role in promoting chronic tissue inflammation. Although Th17 cells are found in human COPD and lung cancer, their role is not understood. We have thus used a mouse model of lung cancer, in which an oncogenic form of K-ras (K-ras(G12D)), frequently found in human lung cancer, is restrictedly expressed in lung epithelial cells [via Clara cell secretory protein (CCSP(cre))]. In this model, Th17 and Treg but not Th1 cells were found enriched at the tumor tissues. When CCSP(cre)/K-ras(G12D) mice were weekly challenged with a lysate of nontypeable Haemophilus influenza (NTHi), which induces COPD-type inflammation and accelerates the tumor growth, they showed greatly enhanced Th17 cell infiltration in the lung tissues. Lack of IL-17, but not IL-17F, resulted in a significant reduction in lung tumor numbers in CCSP(cre)/K-ras(G12D) mice and also those treated with NTHi. Absence of IL-17 not only resulted in reduction of tumor cell proliferation and angiogenesis, but also decreased the expression of proinflammatory mediators and reduced recruitment of myeloid cells. Depletion of Gr-1(+)CD11b(+) myeloid cells in CCSP(cre)/K-ras(G12D) mice suppressed tumor growth in lung, indicating Gr-1(+)CD11b(+) myeloid cells recruited by IL-17 play a protumor role. Taken together, our data demonstrate a critical role for Th17 cell-mediated inflammation in lung tumorigenesis and suggest a novel way for prevention and treatment of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17A has been implicated both in tumor-promoting inflammation and anti-tumor immunity, with contradictory roles being reported for IL-17A in different models of lung cancer (Chang et al., 2014; Cheng et al., 2014).”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Chang et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755 · cited 1×
“I plays an important role in tumor development (1, 2).”
BackgroundThe immune contexture in human tumours: impact on clinical outcome
Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981 · cited 2×
“or foe? Curr Opin Investig Drugs 10(6):543–549.”
BackgroundHarrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265 · cited 2×
“Consistently, we have shown that transgenic overexpression of IL-17 in the lungs resulted in chemokine upregulation and tissue infiltration by leukocytes, although mice treated with neutralizing IL-17–specific antibody were also found to be resistant to the induction of experimental autoimmune encephalomyelitis (9).”
BackgroundSelf-citationCoordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544 · cited 3×
“During tumorigenesis, a heterogeneous population of myeloid cells, known as myeloid-derived suppressive cells, is generated (5).”
BackgroundHerbst, R. S., Heymach, J. V., & Lippman, S. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0802714 · Cited by 2,389
Interleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372 · cited 2×
“Am J Respir Crit Care Med 164(11):2114–2119.”
BackgroundOncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000 · cited 1×
“I plays an important role in tumor development (1, 2).”
BackgroundAnalysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898 · cited 3×
“CCSPCre (27), LSL–K-rasG12D (26), Il17−/−, and Il17f−/− mice (46) have been described.”
MethodWu, S., Rhee, K.-J., Albesiano, E., Rabizadeh, S., Wu, X., Yen, H.-R., Huso, D. L., Brancati, F. L., Wick, E., McAllister, F., et al. (2009) · Nature Medicine · doi:10.1038/nm.2015 · Cited by 1,812
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642 · cited 1×
“Gr-1CD11b cells may directly promote angiogenesis or promote regulatory T cells to enhance tumor in CC-LR mice (5, 40, 41).”
BackgroundAdenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327 · cited 2×
“Our conclusion is in agreement with the recent studies using spontaneous or chemically induced colorectal cancer models (17, 19, 20) and prostate cancer model with Pten deficiency (32).”
BackgroundResultCorzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Manova-Todorova, K., Leversha, M., Hogg, N., Seshan, V. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.042 · Cited by 1,085 · cited 1×
“A recent report indicates CXCL1/2 mediates mammary tumor growth and lung metastasis by recruiting CD11bLy6G granulocytic MDSC population to the tumor site (36).”
BackgroundBayne, L. J., Beatty, G. L., Jhala, N., Clark, C. E., Rhim, A. D., Stanger, B. Z., & Vonderheide, R. H. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.025 · Cited by 947 · cited 3×
“Also, oncogenic K-ras–induced GM-CSF is capable of inducing proliferation and differentiation of c-kit+ Lineage– precursors into functional MDSC (38, 39).”
BackgroundInfluentialTumor-specific Th17-polarized cells eradicate large established melanoma
Muranski, P., Boni, A., Antony, P. A., Cassard, L., Irvine, K. R., Kaiser, A., Paulos, C. M., Palmer, D. C., Touloukian, C. E., Ptak, K., et al. (2008) · Blood · doi:10.1182/blood-2007-11-120998 · Cited by 845
IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway
Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090207 · Cited by 842 · cited 1×
“Because IL-17 can induce IL-6 from tumor and stromal cells, STAT3 activation by IL-6 was proposed as one of mechanisms for protumorigenic role of IL-17 (22).”
BackgroundKryczek, I., Banerjee, M., Cheng, P., Vatan, L., Szeliga, W., Wei, S., Huang, E., Finlayson, E., Simeone, D., Welling, T. H., et al. (2009) · Blood · doi:10.1182/blood-2009-03-208249 · Cited by 813
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Martin-Orozco, N., Muranski, P., Chung, Y., Yang, X. O., Yamazaki, T., Lu, S., Hwu, P., Restifo, N. P., Overwijk, W. W., & Dong, C. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.014 · Cited by 800 · cited 2×
“Despite the increased tumor burden in Il17 mice, tumor lung of Il17 mice expressed reduced Gr-1CD11b myeloid cells in comparison with WT (23).”
BackgroundSelf-citationRegulation of inflammatory responses by IL-17F
Yang, X. O., Chang, S. H., Park, H., Nurieva, R., Shah, B., Acero, L., Wang, Y.-H., Schluns, K. S., Broaddus, R. R., Zhu, Z., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071978 · Cited by 739
Self-citationOncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia
Pylayeva-Gupta, Y., Lee, K. E., Hajdu, C. H., Miller, G., & Bar-Sagi, D. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.04.024 · Cited by 721
Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
Meylan, E., Dooley, A. L., Feldser, D. M., Shen, L., Turk, E., Ouyang, C., & Jacks, T. (2009) · Nature · doi:10.1038/nature08462 · Cited by 517
Tobacco Smoke Promotes Lung Tumorigenesis by Triggering IKKβ- and JNK1-Dependent Inflammation
Takahashi, H., Ogata, H., Nishigaki, R., Broide, D. H., & Karin, M. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.008 · Cited by 438
A Risk Model for Prediction of Lung Cancer
Spitz, M. R., Hong, W. K., Amos, C. I., Wu, X., Schabath, M. B., Dong, Q., Shete, S., & Etzel, C. J. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk153 · Cited by 417 · cited 1×
“Accumulating evidence has shown that inflammation is associated with pathogenesis of lung cancer, especially those induced by cigarette smoke (3).”
BackgroundEndogenous IL-17 contributes to reduced tumor growth and metastasis
Kryczek, I., Wei, S., Szeliga, W., Vatan, L., & Zou, W. (2009) · Blood · doi:10.1182/blood-2008-09-177360 · Cited by 403 · cited 1×
“In other metastasis accompanying models, IL-17 has shown to promote the activation of tumor-specific CD8 T cells that help to eradicate tumor (21, 23, 35).”
BackgroundInterleukin-17 inhibits tumor cell growth by means of a T-cell–dependent mechanism
Benchetrit, F., Ciree, A., Vives, V., Warnier, G., Gey, A., Sautès-Fridman, C., Fossiez, F., Haicheur, N., Fridman, W. H., & Tartour, E. (2002) · Blood · doi:10.1182/blood.v99.6.2114 · Cited by 347 · cited 1×
“In other metastasis accompanying models, IL-17 has shown to promote the activation of tumor-specific CD8 T cells that help to eradicate tumor (21, 23, 35).”
BackgroundK-ras activation generates an inflammatory response in lung tumors
Ji, H., Houghton, A. M., Mariani, T. J., Perera, S., Kim, C. B., Padera, R., Tonon, G., McNamara, K., Marconcini, L. A., Hezel, A., et al. (2006) · Oncogene · doi:10.1038/sj.onc.1209237 · Cited by 271 · cited 3×
“K-ras mutation restrictively expressed in mouse lung epithelial cells led to cellular hyperplasia, adenoma, and eventually adenocarcinoma, resembling human lung cancer development (25, 28).”
BackgroundAblation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis
Chae, W.-J., Gibson, T. F., Zelterman, D., Hao, L., Henegariu, O., & Bothwell, A. L. M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912675107 · Cited by 243 · cited 1×
“Our conclusion is in agreement with the recent studies using spontaneous or chemically induced colorectal cancer models (17, 19, 20) and prostate cancer model with Pten deficiency (32).”
ResultIncreased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients
Chen, X., Wan, J., Liu, J., Xie, W., Diao, X., Xu, J., Zhu, B., & Chen, Z. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2009.11.013 · Cited by 217 · cited 1×
“The density of intratumoral IL-17– positive cells in primary human nonsmall cell lung cancer was inversely correlated with patient outcome and correlated with smoking status of the patients (14).”
BackgroundExpression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer
Blatner, N. R., Mulcahy, M. F., Dennis, K. L., Scholtens, D., Bentrem, D. J., Phillips, J. D., Ham, S., Sandall, B. P., Khan, M. W., Mahvi, D. M., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004566 · Cited by 211
BANDI, V., APICELLA, M. A., MASON, E., MURPHY, T. F., SIDDIQI, A., ATMAR, R. L., & GREENBERG, S. B. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2104093 · Cited by 195 · cited 11×
“In addition, we induced COPD-type lung inflammation by challenging mice with lysates of nontypeable Haemophilus influenza (NTHi).”
BackgroundInfluentialShan, M., Yuan, X., Song, L.-Z., Roberts, L., Zarinkamar, N., Seryshev, A., Zhang, Y., Hilsenbeck, S., Chang, S.-H., Dong, C., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003041 · Cited by 187 · cited 1×
“We and others have previously used an experimental model of smoke exposure and demonstrated IL-17–deficient mice are resistant to smoke-induced airway inflammation and emphysema (43, 44).”
MethodSelf-citationChen, K., Pociask, D. A., McAleer, J. P., Chan, Y. R., Alcorn, J. F., Kreindler, J. L., Keyser, M. R., Shapiro, S. D., Houghton, A. M., Kolls, J. K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020333 · Cited by 167 · cited 1×
“We and others have previously used an experimental model of smoke exposure and demonstrated IL-17–deficient mice are resistant to smoke-induced airway inflammation and emphysema (43, 44).”
MethodWislez, M., Fujimoto, N., Izzo, J. G., Hanna, A. E., Cody, D. D., Langley, R. R., Tang, H., Burdick, M. D., Sato, M., Minna, J. D., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3842 · Cited by 164
A Protective Role by Interleukin-17F in Colon Tumorigenesis
Tong, Z., Yang, X. O., Yan, H., Liu, W., Niu, X., Shi, Y., Fang, W., Xiong, B., Wan, Y., & Dong, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034959 · Cited by 160 · cited 1×
“Our conclusion is in agreement with the recent studies using spontaneous or chemically induced colorectal cancer models (17, 19, 20) and prostate cancer model with Pten deficiency (32).”
ResultSelf-citationLung Myeloid Dendritic Cells Coordinately Induce T H 1 and T H 17 Responses in Human Emphysema
Shan, M., Cheng, H.-F., Song, L.-Z., Roberts, L., Green, L., Hacken-Bitar, J., Huh, J., Bakaeen, F., Coxson, H. O., Storness-Bliss, C., et al. (2009) · Science Translational Medicine · doi:10.1126/scitranlsmed.3000154 · Cited by 159 · cited 1×
“Analysis of human lung cells from emphysema patients revealed infiltration of Th17 cells (42).”
BackgroundPromoting effect of neutrophils on lung tumorigenesis is mediated by CXCR2 and neutrophil elastase
Gong, L., Cumpian, A. M., Caetano, M. S., Ochoa, C. E., De la Garza, M. M., Lapid, D. J., Mirabolfathinejad, S. G., Dickey, B. F., Zhou, Q., & Moghaddam, S. J. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-154 · Cited by 150 · cited 1×
“Gr-1CD11b cells may directly promote angiogenesis or promote regulatory T cells to enhance tumor in CC-LR mice (5, 40, 41).”
BackgroundSelf-citationMoghaddam, S. J., Li, H., Cho, S.-N., Dishop, M. K., Wistuba, I. I., Ji, L., Kurie, J. M., Dickey, B. F., & DeMayo, F. J. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0198oc · Cited by 146 · cited 5×
“It has been also shown that NTHi challenge in CC-LR mice resulted in lung cancer promotion (25).”
BackgroundInfluentialSelf-citationInterleukin-17 Promotes Formation and Growth of Prostate Adenocarcinoma in Mouse Models
Zhang, Q., Liu, S., Ge, D., Zhang, Q., Xue, Y., Xiong, Z., Abdel-Mageed, A. B., Myers, L., Hill, S. M., Rowan, B. G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3795 · Cited by 98
A role for T-bet-mediated tumour immune surveillance in anti-IL-17A treatment of lung cancer
Reppert, S., Boross, I., Koslowski, M., Türeci, Ö., Koch, S., Lehr, H. A., & Finotto, S. (2011) · Nature Communications · doi:10.1038/ncomms1609 · Cited by 86
The IL-17/IL-23 axis of inflammation in cancer: friend or foe?
Martín‐Orozco, N., & Dong, C. (2009) · PubMed · Cited by 73
Self-citationHamaï, A., Pignon, P., Raimbaud, I., Duperrier-Amouriaux, K., Senellart, H., Hiret, S., Douillard, J.-Y., Bennouna, J., Ayyoub, M., & Valmori, D. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3432 · Cited by 55
IL-17 mediates resistance to anti-VEGF therapy
Maniati, E., & Hagemann, T. (2013) · Nature Medicine · doi:10.1038/nm.3333 · Cited by 40 · cited 1×
“A recent study demonstrated that IL-17 promotes tumor resistance to VEGF inhibition due to its ability of Gr-1CD11b cell mobilization and recruitment (33).”
BackgroundCelli, B. R. (2012) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201107-039ms · Cited by 38 · cited 11×
“In addition, we induced COPD-type lung inflammation by challenging mice with lysates of nontypeable Haemophilus influenza (NTHi).”
BackgroundInfluentialCre‐mediated recombination in mouse Clara cells
Li, H., Cho, S. N., Evans, C. M., Dickey, B. F., Jeong, J., & DeMayo, F. J. (2008) · genesis · doi:10.1002/dvg.20396 · Cited by 32
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
“In a Kras -driven lung adenocarcinoma mouse model, IL-17-responsive TANs promote tumor growth (Chang et al. 2014).”
BackgroundNeutrophils in cancer: Neutral no more
Coffelt, S. B., Wellenstein, M. D., & de Visser, K. E. (2016) · Nature reviews. Cancer · doi:10.1038/nrc.2016.52 · Cited by 1,830
Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Jin, C., Lagoudas, G. K., Zhao, C., Bullman, S., Bhutkar, A., Hu, B., Ameh, S., Sandel, D., Liang, X. S., Mazzilli, S., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.040 · Cited by 964
Myc Cooperates with Ras by Programming Inflammation and Immune Suppression
Kortlever, R. M., Sodir, N. M., Wilson, C. H., Burkhart, D. L., Pellegrinet, L., Brown Swigart, L., Littlewood, T. D., & Evan, G. I. (2017) · Cell · doi:10.1016/j.cell.2017.11.013 · Cited by 553
“N See also Figures S1 and S7. immunosuppressive (Bailey et al., 2014; Chang, 2015; Chang et al., 2014).”
Background
Metadata
- Authors
- Chang, S. H., Mirabolfathinejad, S. G., Katta, H., Cumpian, A. M., Gong, L., Caetano, M. S., Moghaddam, S. J., & Dong, C.
- Affiliations
- The University of Texas MD Anderson Cancer Center (US)
- Departments of aImmunology and
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2014-03-31
- Volume
- 111
- Issue
- 15
- Pages
- 5664-5669
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3992670
- OpenAlex
- W2053968039
- Cited by
- 326
- References
- 46
- Citations by year
- 2026: 11 · 2025: 22 · 2024: 26 · 2023: 29 · 2022: 33 · 2021: 28 · 2020: 36 · 2019: 28 · 2018: 21 · 2017: 29 · 2016: 29 · 2015: 24 · 2014: 9
- FWCI
- 13.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P30CA016672)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- Th17 cells, lung cancer, chronic obstructive pulmonary disease, IL-17, KRAS G12D, nontypeable Haemophilus influenzae, tumor inflammation, tumor microenvironment, regulatory T cells, angiogenesis, tumor cell proliferation, pro-inflammatory mediators, myeloid cell recruitment
- MeSH terms
- Animals, Flow Cytometry, Haemophilus influenzae, Immunohistochemistry, Lung Neoplasms, Mice, Mutant Strains, Mutation, Pneumonia, Genes, ras, Uteroglobin, DNA Primers, Myeloid Cells, Pulmonary Disease, Chronic Obstructive, Mice, Th17 Cells, Real-Time Polymerase Chain Reaction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.